Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Zurich | OTHER |
Not provided
Not provided
Not provided
Not provided
The "BPET prototype" is a small aperture PET scanner. The BPET prototype will be used with patients, which have just finished their regularly scheduled PET examination on a clinical whole body PET system. The radioactive tracer used for this procedure will still be active. This remaining acitivity will be used for an image acquisition with the BPET prototype without the need for an additional radioactive tracer dose.
The control intervention is be a brain PET scan as part of standard clinical routine. It will be done immediately before the scan on the BPET prototype.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BPET Scan | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BPET Prototype Scan | Device | Scan on the BPET Prototype PET system and qualitative comparison with a PET image acquired on a conventional clinical PET system. |
|
| Measure | Description | Time Frame |
|---|---|---|
| PET image of the brain | The primary outcome will be a PET image of the brain for each participant taken on BPET. It will be compared against the image taken by the conventional PET machine by a trained physician and judged by whether it could be used for diagnosis and further analysis. | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Usability (patient feedback for seat comfort) | The secondary outcome with respect to usability will be feedback from patients with respect to patient seat comfort. | 1 day |
| Usability (medical technologist feedback for ease of positioning) |
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of adverse events | Safety of the procedure will be assessed by documenting adverse events (description of the adverse events, number of participants) | During the imaging procedure which should last 15 minutes. |
| Assessment of device deficiencies |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Martin Hüllner, PD Dr. med. | University of Zurich | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| PET Center Schlieren | Schlieren | Canton of Zurich | 8952 | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| ID | Term |
|---|---|
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The secondary outcome with respect to usability will be feedback from medical technologist with respect to easiness of patient positioning.
| 1 day |
Safety of the procedure will be assessed by documenting device deficiencies (description of the deficiency).
| During the imaging procedure which should last 15 minutes. |
| Identification of new risks | Safety of the procedure will be assessed by identifying and documenting any new risk. | During the imaging procedure which should last 15 minutes. |